1392278-76-0

iRGD peptide Chemical Structure
1392278-76-0

Chemical Structure

iRGD peptide

Synonym(s): c(CRGDKGPDC)

  • CAS No.: 1392278-76-0
  • Formula:C35H57N13O14S2
  • Molecular Weight:948.04

IUPAC Name: 2,2'-((3S,6R,11R,14S,20S,23S,31aS)-11-amino-23-(4-aminobutyl)-6-carboxy-14-(3-guanidinopropyl)-1,4,12,15,18,21,24,27-octaoxooctacosahydro-1H-pyrrolo[2,1-j][1,2]dithia[5,8,11,14,17,20,23,26]octaazacyclononacosine-3,20-diyl)diacetic acid

InChIKey: YHTTWXCDIRTOQX-FQJIPJFPSA-N

SMILES: O=C([C@@H](N)CSSC[C@H](NC1=O)C(O)=O)N[C@H](C(NCC(N[C@H](C(N[C@H](C(NCC(N2[C@H](C(N[C@H]1CC(O)=O)=O)CCC2)=O)=O)CCCCN)=O)CC(O)=O)=O)=O)CCCNC(N)=N

Biological Activity: iRGD peptide is a 9-amino acid cyclic peptide, triggers tissue penetration of agents by first binding to αv-integrins, then proteolytically cleaved in the tumor to produce CRGDK/R to interact with neuropilin-1, and has tumor-targeting and tumor-penetrating properties.

Cat. No. Product Name Purity Description Pricing
HY-P0122
iRGD peptide 98.49% iRGD peptide is a 9-amino acid cyclic peptide, triggers tissue penetration of agents by first binding to αv-integrins, then proteolytically cleaved in the tumor to produce CRGDK/R to interact with neuropilin-1, and has tumor-targeting and tumor-penetrating properties.
Pricing 
Expand Hide
loading...
/
  • /
loading...
Size Price
Stock Quantity Availability Operate
/
In-stock
(Estimated to ship on )
(Estimated to ship TODAY)
Estimated to ship on
(Estimated to ship TODAY)

Amount:

USD 0.00

This product is a controlled substance and not for sale in your territory.

This product is not for sale in your territory.

This compound is listed in the SVHC (Substances of Very High Concern) candidate list of ECHA (European Chemicals Agency).

Pricing 
Expand Hide